New Phase 3 Post Hoc Analyses of Centanafadine for the Treatment of Adults With ADHD

Source Summary

New phase 3 analyses show centanafadine improves adult ADHD executive function and emotional regulation beyond core symptoms, as FDA review advances toward July 2026.